Search research articles
Contact Us
Filters
Showing results (71-80 of 112) with videos related to
Page
of 12
Sort By:
Onkologie
|
October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Oncology Letters
|
October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
Umut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
World Journal of Urology
|
January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology
Ahmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 15, 2020
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 25, 2015
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)
Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, et al.
Cancer Medicine
|
December 23, 2023
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 27, 2019
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, et al.
Future Oncology (London, England)
|
July 24, 2025
Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study
Mehmet Ali Nahit Sendur, Nuri Karadurmus, Irfan Cicin, et al.
Breast (Edinburgh, Scotland)
|
January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
January 28, 2014
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology
Veli Berk, Mehmet Ali Kaplan, Onder Tonyali, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 112) with videos related to
Sort By:
Page
of 12
Onkologie
|
October 11, 2013
Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Nur Sener, et al.
Oncology Letters
|
October 19, 2013
Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience
Umut Kefeli, Mustafa Benekli, Alper Sevinc, et al.
World Journal of Urology
|
January 22, 2015
Treatment preferences in stage IA and IB testicular seminoma: multicenter study of Anatolian Society of Medical Oncology
Ahmet Bilici, Turkan Ozturk, Esma Turkmen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 15, 2020
Neutrophil-lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study)
Mutlu Hizal, Mehmet An Sendur, Hatime Arzu Yasar, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
June 25, 2015
Adult Urological Soft Tissue Sarcomas: A Multicenter Study of the Anatolian Society of Medical Oncology (ASMO)
Olcun Umit Unal, Ilhan Oztop, Serkan Menekse, et al.
Cancer Medicine
|
December 23, 2023
The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study
Deniz Can Guven, Musa Baris Aykan, Harun Muglu, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
October 27, 2019
The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer
Hatime Arzu Yasar, Kadriye Bir Yucel, Cagatay Arslan, et al.
Future Oncology (London, England)
|
July 24, 2025
Evaluation of implementation of evolving practice patterns in the first-line treatment of patients with metastatic non-small cell lung cancer in Turkiye (ESTIMATE): a national, multicenter, retrospective, real-world evidence study
Mehmet Ali Nahit Sendur, Nuri Karadurmus, Irfan Cicin, et al.
Breast (Edinburgh, Scotland)
|
January 24, 2016
Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
Onder Tonyali, Ugur Coskun, Sinemis Yuksel, et al.
Asian Pacific Journal of Cancer Prevention : APJCP
|
January 28, 2014
Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology
Veli Berk, Mehmet Ali Kaplan, Onder Tonyali, et al.
Page
of 12